Posted on Wednesday, May 1, 2013 - 09:23, By: Amy Madsen
Name: Rasagiline. This drug is approved by the U.S. Food and Drug Administration for the treatment of Parkinson’s disease; it is marketed under the brand name Azilect.

Research news about clinical trials testing a Parkinson’s drug and stem cells in ALS reported at the 65th annual meeting of the American Academy of Neurology

Posted on Friday, March 22, 2013 - 16:45, By: Amy Madsen
Update (July 30, 2013): BrainStorm Cell Therapeutics announced in a July 29, 2013, press release that the European Commission has granted Orphan Drug Designation to the company’s NurOwn stem cell therapy for the treatment of ALS.